We are live on ! Find out more
CEROW

CERo Therapeutics Warrants

Delisted

CEROW was delisted on the 30th of October, 2025.

1 hedge funds and large institutions have $22 invested in CERo Therapeutics Warrants in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% less funds holding

Funds holding: 221 (-21)

100% less capital invested

Capital invested by funds: $38.1K → $22 (-$38.1K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 21

3,090.99% less ownership

Funds ownership: 3,093.71%2.72% (-3,091%)

Holders
1
Holders Change
-21
Holders Change %
-95.45%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
21
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AA
1
Ancora Advisors
Ohio
$22
CS
2
Clear Street
New York
-$6.14K -461,653 Closed
Toronto Dominion Bank
3
Toronto Dominion Bank
Ontario, Canada
-$5.33K -381,018 Closed
MI
4
MMCAP International
Cayman Islands
-$4.99K -375,000 Closed
SCM
5
Saba Capital Management
New York
-$4.26K -295,913 Closed
LA
6
Linden Advisors
New York
-$3.6K -249,999 Closed
BOCH
7
Blue Owl Capital Holdings
New York
-$2.99K -224,930 Closed
QGA
8
Q Global Advisors
Texas
-$2K -170,785 Closed
CCM
9
Context Capital Management
California
-$1.62K -122,013 Closed
NAM
10
Nexpoint Asset Management
Texas
-$1.45K -108,741 Closed
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
-$1.31K -98,468 Closed
PMAM
12
Picton Mahoney Asset Management
Ontario, Canada
-$1K -75,000 Closed
WCMNY
13
Westchester Capital Management (New York)
New York
-$997 -74,998 Closed
TCM
14
Tenor Capital Management
New York
-$665 -50,000 Closed
WAM
15
Wolverine Asset Management
Illinois
-$449 -33,796 Closed
PA
16
Parallel Advisors
California
-$366 -27,500 Closed
WA
17
Whitebox Advisors
Minnesota
-$309 -23,250 Closed
Calamos Advisors
18
Calamos Advisors
Illinois
-$166 -12,500 Closed
DCM
19
Dupont Capital Management
Delaware
-$166 -12,500 Closed
SRF
20
Silver Rock Financial
California
-$163 -12,224 Closed
FFS
21
Fortress Financial Solutions
Arizona
-$133 -10,000 Closed

CEROW Hedge Fund Activity: Q4 2025 in Review

1 of the 8,232 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q4 2025, worth a combined $22 — down 100% from $38.1K a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of CEROW and 0 opened new positions — a net loss of 21 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Clear Street, exiting entirely with an estimated $6.14K sold.

  • 1 institutional investor held CERo Therapeutics Warrants (CEROW) as of Q4 2025, down from 22 in Q3 2025.
  • Funds reported $22 of CERo Therapeutics Warrants stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new CERo Therapeutics Warrants positions in Q4 2025 and 21 closed out, a net change of -21 holders.
  • The largest CERo Therapeutics Warrants seller in Q4 2025 was Clear Street, an estimated $6.14K sold.

Based on aggregated 13F filings for Q4 2025.